Culturally Adapted Hypertension Education (CAHE) to Improve Blood Pressure Control and Treatment Adherence in Patients of African Origin with Uncontrolled Hypertension: Cluster-Randomized Trial
Objectives To evaluate the effect of a practice-based, culturally appropriate patient education intervention on blood pressure (BP) and treatment adherence among patients of African origin with uncontrolled hypertension. Methods Cluster randomised trial involving four Dutch primary care centres and 146 patients (intervention n = 75, control n = 71), who met the following inclusion criteria: self-identified Surinamese or Ghanaian; ≥20 years; treated for hypertension; SBP≥140 mmHg. All patients received usual hypertension care. The intervention-group was also offered three nurse-led, culturally appropriate hypertension education sessions. BP was assessed with Omron 705-IT and treatment adherence with lifestyle- and medication adherence scales. Results 139 patients (95%) completed the study (intervention n = 71, control n = 68). Baseline characteristics were largely similar for both groups. At six months, we observed a SBP reduction of ≥10 mmHg -primary outcome- in 48% of the intervention group and 43% of the control group. When adjusted for pre-specified covariates age, sex, hypertension duration, education, baseline measurement and clustering effect, the between-group difference was not significant (OR; 0.42; 95% CI: 0.11 to 1.54; P = 0.19). At six months, the mean SBP/DBD had dropped by 10/5.7 (SD 14.3/9.2)mmHg in the intervention group and by 6.3/1.7 (SD 13.4/8.6)mmHg in the control group. After adjustment, between-group differences in SBP and DBP reduction were ？1.69 mmHg (95% CI: ？6.01 to 2.62, P = 0.44) and ？3.01 mmHg (？5.73 to ？0.30, P = 0.03) in favour of the intervention group. Mean scores for adherence to lifestyle recommendations increased in the intervention group, but decreased in the control group. Mean medication adherence scores improved slightly in both groups. After adjustment, the between-group difference for adherence to lifestyle recommendations was 0.34 (0.12 to 0.55; P = 0.003). For medication adherence it was ？0.09 (？0.65 to 0.46; P = 0.74). Conclusion This intervention led to significant improvements in DBP and adherence to lifestyle recommendations, supporting the need for culturally appropriate hypertension care. Trial Registration Controlled-Trials.com ISRCTN35675524
References
[1]
Cappuccio FP (1997) Ethnicity and cardiovascular risk: variations in people of African ancestry and South Asian origin. J Hum Hypertens 11: 571–576. doi: 10.1038/sj.jhh.1000516
[2]
Raleigh VS (1997) Diabetes and hypertension in Britain's ethnic minorities: implications for the future of renal services. BMJ 314: 209–213. doi: 10.1136/bmj.314.7075.209
[3]
Douglas JG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, et al. (2003) Management of High Blood Pressure in African Americans: Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 163: 525–541. doi: 10.1001/archinte.163.5.525
[4]
Agyemang C, Bindraban N, Mairuhu G, Montfrans G, Koopmans R, et al. (2005) Prevalence, awareness, treatment, and control of hypertension among Black Surinamese, South Asian Surinamese and White Dutch in Amsterdam, The Netherlands: the SUNSET study. J Hypertens 23: 1971–1977. doi: 10.1097/01.hjh.0000186835.63996.d4
[5]
Agyemang C, Nicolaou M, Boateng L, Dijkshoorn H, van de Born BJ, et al. (2012) Prevalence, awareness, treatment, and control of hypertension among Ghanaian population in Amsterdam, the Netherlands: the GHAIA study. Eur J Prev Cardiol 2047487312451540 [pii];10.1177/2047487312451540 [doi]. doi: 10.1177/2047487312451540
[6]
Agyemang C, van Valkengoed I, Koopmans R, Stronks K (2006) Factors associated with hypertension awareness, treatment and control among ethnic groups in Amsterdam, the Netherlands: the SUNSET study. J Hum Hypertens 20: 874–881 10.1038/sj.jhh.1002073. doi: 10.1038/sj.jhh.1002073
[7]
Bosworth HB, Dudley T, Olsen MK, Voils CI, Powers B, et al. (2006) Racial Differences in Blood Pressure Control: Potential Explanatory Factors. The American Journal of Medicine 119: 70. doi: 10.1016/j.amjmed.2005.08.019
[8]
van den Born BJ, Koopmans RP, Groeneveld JO, van Montfrans GA (2006) Ethnic disparities in the incidence, presentation and complications of malignant hypertension. J Hypertens 24: 2299–2304. doi: 10.1097/01.hjh.0000249710.21146.38
[9]
Miller NH, Hill M, Kottke T, Ockene IS (1997) The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation 95: 1085–1090. doi: 10.1161/01.cir.95.4.1085
[10]
Cooper L, Roter D, Bone L, Larson S, Miller E, et al. (2009) A randomized controlled trial of interventions to enhance patient-physician partnership, patient adherence and high blood pressure control among ethnic minorities and poor persons: study protocol NCT00123045. Implementation Science 4: 7 10.1186/1748-5908-4-7. doi: 10.1186/1748-5908-4-7
[11]
De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, et al. (2003) European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur Heart J 24: 1601–1610. doi: 10.1016/s0195-668x(03)00347-6
[12]
Wiersma T, Walma EP, Thomas S, Assendelft WJ (2004) [Summary of the practice guideline ‘Hypertension’ (third division) from the Dutch College of General Practitioners]. Ned Tijdschr Geneeskd 148: 923–931.
[13]
Kleinman A, Eisenberg L, Good B (2006) Culture, Illness, and Care: Clinical Lessons From Anthropologic and Cross-Cultural Research. Focus 4: 140–149. doi: 10.7326/0003-4819-88-2-251
[14]
Boulware LE, Daumit GL, Frick KD, Minkovitz CS, Lawrence RS, et al. (2001) An evidence-based review of patient-centered behavioral interventions for hypertension. American Journal of Preventive Medicine 21: 221–232. doi: 10.1016/s0749-3797(01)00356-7
[15]
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 289: 2560–2571. doi: 10.1001/jama.289.19.2560
[16]
Krousel-Wood M, Hyre A, Muntner P, Morisky D (2005) Methods to improve medication adherence in patients with hypertension: current status and future directions. Curr Opin Cardiol 20: 296–300. doi: 10.1097/01.hco.0000166597.52335.23
[17]
Saha S (2008) Patient Centeredness, Cultural Competence and Healthcare Quality. Journal of the National Medical Association 100: 1275–1284.
[18]
Whitlock EP, Orleans CT, Pender N, Allan J (2002) Evaluating primary care behavioral counseling interventions: An evidence-based approach. American Journal of Preventive Medicine 22: 267–284 doi: 10.1016/S0749-3797(02)00415-4.
[19]
Heurtin-Roberts S, Reisin E (1992) The relation of culturally influenced lay models of hypertension to compliance with treatment. Am J Hypertens 5: 787–792.
[20]
Morgan M (1995) The significance of ethnicity for health promotion: patients' use of anti-hypertensive drugs in inner London. Int J Epidemiol 24 Suppl 1: S79–S84. doi: 10.1093/ije/24.supplement_1.s79
[21]
Brown CM, Segal R (1996) The effects of health and treatment perceptions on the use of prescribed medication and home remedies among African American and white American hypertensives. Soc Sci Med 43: 903–917. doi: 10.1016/0277-9536(95)00434-3
[22]
Brown CM, Segal R (1996) Ethnic differences in temporal orientation and its implications for hypertension management. J Health Soc Behav 37: 350–361. doi: 10.2307/2137262
[23]
Wilson RP, Freeman A, Kazda MJ, Andrews TC, Berry L, et al. (2002) Lay beliefs about high blood pressure in a low- to middle-income urban African-American community: an opportunity for improving hypertension control. The American Journal of Medicine 112: 26–30. doi: 10.1016/s0002-9343(01)01049-x
[24]
Beune EJ, Haafkens JA, Agyemang C, Schuster JS, Willems DL (2008) How Ghanaian, African-Surinamese and Dutch patients perceive and manage antihypertensive drug treatment: a qualitative study. J Hypertens 26: 648–656. doi: 10.1097/hjh.0b013e3282f4d20b
[25]
Beune EJ, Haafkens JA, Agyemang C, Bindels PJ (2009) Inhibitors and enablers of physical activity in multiethnic hypertensive patients: qualitative study. J Hum Hypertens jhh200961 [pii];10.1038/jhh.2009.61 [doi]. doi: 10.1038/jhh.2009.61
Cooper LA, Hill MN, Powe NR (2002) Designing and Evaluating Interventions to Eliminate Racial and Ethnic Disparities in Health Care. J Gen Intern Med 17: 477–486 10.1046/j.1525-1497.2002.10633.x [doi]. doi: 10.1046/j.1525-1497.2002.10633.x
[28]
Netto G, Bhopal R, Lederle N, Khatoon J, Jackson A (2010) How can health promotion interventions be adapted for minority ethnic communities? Five principles for guiding the development of behavioural interventions. Health Promotion International 25: 248–257. doi: 10.1093/heapro/daq012
[29]
Connell P, Wolfe C, McKevitt C (2008) Preventing stroke: a narrative review of community interventions for improving hypertension control in black adults. Health Soc Care Community 16: 165–187 HSC737 [pii];10.1111/j.1365-2524.2007.00737.x [doi]. doi: 10.1111/j.1365-2524.2007.00737.x
[30]
Saha S, Beach MC, Cooper LA (2008) Patient centeredness, cultural competence and healthcare quality. J Natl Med Assoc 100: 1275–1285.
[31]
Odedosu T, Schoenthaler A, Vieira DL, Agyemang C, Ogedegbe G (2012) Overcoming barriers to hypertension control in African Americans. Cleve Clin J Med 79: 46–56 79/1/46 [pii];10.3949/ccjm.79a.11068 [doi]. doi: 10.3949/ccjm.79a.11068
[32]
Beach MC, Gary TL, Price EG, Robinson K, Gozu A, et al. (2006) Improving health care quality for racial/ethnic minorities: a systematic review of the best evidence regarding provider and organization interventions. BMC Public Health 6: 104.
[33]
Beune EJAJ, Haafkens JA, Bindels PJE (2011) Barriers and enablers in the implementation of a provider-based intervention to stimulate culturally appropriate hypertension education. Patient Education and Counseling 82: 74–80 doi: 10.1016/j.pec.2010.02.015.
[34]
Haafkens J, Beune E, van Charante E, Agyemang C (2009) A cluster-randomized controlled trial evaluating the effect of culturally-appropriate hypertension education among Afro-Surinamese and Ghanaian patients in Dutch general practice: study protocol. BMC Health Services Research 9: 193 10.1186/1472-6963-9-193. doi: 10.1186/1472-6963-9-193
[35]
Smulders YM, Burgers JS, Scheltens T, van Hout BA, Wiersma T, et al. (2008) Clinical practice guideline for cardiovascular risk management in the Netherlands. Neth J Med 66: 169–174.
[36]
Aspinall PJ (2001) Operationalising the collection of ethnicity data in studies of the sociology of health and illness. Sociology of health & illness 23: 829–862. doi: 10.1111/1467-9566.00277
[37]
Morisky DE, Green LW, Levine DM (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24: 67–74. doi: 10.1097/00005650-198601000-00007
[38]
Morisky DE, Ang A, Krousel-Wood M, Ward HJ (2008) Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 10: 348–354. doi: 10.1111/j.1751-7176.2008.07572.x
[39]
Ogedegbe G, Schoenthaler A, Richardson T, Lewis L, Belue R, et al. (2007) An RCT of the effect of motivational interviewing on medication adherence in hypertensive African Americans: rationale and design. Contemp Clin Trials 28: 169–181 S1551-7144(06)00046-2 [pii];10.1016/j.cct.2006.04.002 [doi]. doi: 10.1016/j.cct.2006.04.002
[40]
Shea S, Misra D, Ehrlich MH, Field L, Francis CK (1992) Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health 82: 1607–1612. doi: 10.2105/ajph.82.12.1607
[41]
Schoenthaler A, Chaplin WF, Allegrante JP, Fernandez S, Diaz-Gloster M, et al. (2009) Provider communication effects medication adherence in hypertensive African Americans. Patient Educ Couns 75: 185–191 S0738-3991(08)00527-2 [pii];10.1016/j.pec.2008.09.018 [doi]. doi: 10.1016/j.pec.2008.09.018
[42]
Liu K, Dyer AR, Cooper RS, Stamler R, Stamler J (1979) Can overnight urine replace 24-hour urine collection to asses salt intake? Hypertension 1: 529–536. doi: 10.1161/01.hyp.1.5.529
[43]
Campbell M, Grimshaw J, Steen N (2000) Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action). J Health Serv Res Policy 5: 12–16.
[44]
Staessen JA, Wang JG, Thijs L (2001) Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 358: 1305–1315 S0140-6736(01)06411-X [pii];10.1016/S0140-6736(01)06411-X [doi]. doi: 10.1016/s0140-6736(01)06411-x
[45]
Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, et al. (2003) Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 289: 2083–2093 10.1001/jama.289.16.2083 [doi];289/16/2083 [pii]. doi: 10.1001/jama.289.16.2083
[46]
Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, et al. (2001) Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med 135: 1019–1028 200112180-00005 [pii]. doi: 10.7326/0003-4819-135-12-200112180-00005
[47]
Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, et al. (2009) New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 15: 59–66 11024 [pii].
[48]
Cooper LA, Roter DL, Carson KA, Bone LR, Larson SM, et al. (2011) A randomized trial to improve patient-centered care and hypertension control in underserved primary care patients. J Gen Intern Med 26: 1297–1304 10.1007/s11606-011-1794-6 [doi]. doi: 10.1007/s11606-011-1794-6
[49]
Ogedegbe G, Chaplin W, Schoenthaler A, Statman D, Berger D, et al. (2008) A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens 21: 1137–1143 ajh2008240 [pii];10.1038/ajh.2008.240 [doi].
[50]
Bosworth HB, Olsen MK, Grubber JM, Powers BJ, Oddone EZ (2011) Racial Differences in Two Self-Management Hypertension Interventions. The American Journal of Medicine 124: 468 doi: 10.1016/j.amjmed.2010.11.024.
[51]
Houston TK, Allison JJ, Sussman M, Horn W, Holt CL, et al. (2011) Culturally appropriate storytelling to improve blood pressure: a randomized trial. Ann Intern Med 154: 77–84 154/2/77 [pii];10.1059/0003-4819-154-2-201101180-？00004[doi]. doi: 10.7326/0003-4819-154-2-201101180-00004
[52]
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 289: 2560–2571 10.1001/jama.289.19.2560. doi: 10.1001/jama.289.19.2560
[53]
Cook NR, Cohen J, Hebert PR, Taylor JO, Hennekens CH (1995) Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 155: 701–709. doi: 10.1001/archinte.1995.00430070053006
